# Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS

> **NCT01702987** · NA · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 22 (actual)

## Conditions studied

- Myopathy
- HMG COA Reductase Inhibitor Adverse Reaction
- Hypercholesterolemia

## Interventions

- **DIETARY_SUPPLEMENT:** ubiquinol
- **DIETARY_SUPPLEMENT:** placebo
- **DRUG:** statin

## Key facts

- **NCT ID:** NCT01702987
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702987, "Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01702987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*